These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16708075)

  • 1. p53: more research and more questions.
    Braithwaite AW; Prives CL
    Cell Death Differ; 2006 Jun; 13(6):877-80. PubMed ID: 16708075
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
    Johnson TM; Attardi LD
    Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of p53 responses by post-translational modifications.
    Xu Y
    Cell Death Differ; 2003 Apr; 10(4):400-3. PubMed ID: 12719715
    [No Abstract]   [Full Text] [Related]  

  • 4. Translational research? Ribosome integrity and a new p53 tumor suppressor checkpoint.
    Opferman JT; Zambetti GP
    Cell Death Differ; 2006 Jun; 13(6):898-901. PubMed ID: 16557265
    [No Abstract]   [Full Text] [Related]  

  • 5. p53: 25 years of research and more questions to answer.
    Bourdon JC; Laurenzi VD; Melino G; Lane D
    Cell Death Differ; 2003 Apr; 10(4):397-9. PubMed ID: 12719714
    [No Abstract]   [Full Text] [Related]  

  • 6. The continuing saga of p53--more sleepless nights ahead.
    Prives C; Manfredi JJ
    Mol Cell; 2005 Sep; 19(6):719-21. PubMed ID: 16168367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 downstream target genes and tumor suppression: a classical view in evolution.
    Rozan LM; El-Deiry WS
    Cell Death Differ; 2007 Jan; 14(1):3-9. PubMed ID: 17068503
    [No Abstract]   [Full Text] [Related]  

  • 8. Twenty years of p53 research: structural and functional aspects of the p53 protein.
    May P; May E
    Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
    [No Abstract]   [Full Text] [Related]  

  • 9. Rules for making human tumor cells.
    Hahn WC; Weinberg RA
    N Engl J Med; 2002 Nov; 347(20):1593-603. PubMed ID: 12432047
    [No Abstract]   [Full Text] [Related]  

  • 10. Stressing the role of FoxO proteins in lifespan and disease.
    van der Horst A; Burgering BM
    Nat Rev Mol Cell Biol; 2007 Jun; 8(6):440-50. PubMed ID: 17522590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The P53 pathway: what questions remain to be explored?
    Levine AJ; Hu W; Feng Z
    Cell Death Differ; 2006 Jun; 13(6):1027-36. PubMed ID: 16557269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-dependent translational control of senescence and transformation via 4E-BPs.
    Petroulakis E; Parsyan A; Dowling RJ; LeBacquer O; Martineau Y; Bidinosti M; Larsson O; Alain T; Rong L; Mamane Y; Paquet M; Furic L; Topisirovic I; Shahbazian D; Livingstone M; Costa-Mattioli M; Teodoro JG; Sonenberg N
    Cancer Cell; 2009 Nov; 16(5):439-46. PubMed ID: 19878875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
    Kitagawa M; Lee SH; McCormick F
    Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Populations of p53 codon 270 CGT to TGT mutant cells in SKH-1 mouse skin tumors induced by simulated solar light.
    Verkler TL; Delongchamp RR; Couch LH; Miller BJ; Warbritton A; Mellick PW; Howard PC; Parsons BL
    Mol Carcinog; 2008 Nov; 47(11):822-34. PubMed ID: 18381587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
    Hrstka R; Powell DJ; Kvardova V; Roubalova E; Bourougaa K; Candeias MM; Sova P; Zak F; Fåhraeus R; Vojtĕsek B
    Anticancer Drugs; 2008 Apr; 19(4):369-79. PubMed ID: 18454047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth.
    Bocchetta M; Eliasz S; De Marco MA; Rudzinski J; Zhang L; Carbone M
    Cancer Res; 2008 Feb; 68(4):1022-9. PubMed ID: 18281476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
    Olsson A; Manzl C; Strasser A; Villunger A
    Cell Death Differ; 2007 Sep; 14(9):1561-75. PubMed ID: 17627286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 alterations in human cancer: more questions than answers.
    Soussi T
    Oncogene; 2007 Apr; 26(15):2145-56. PubMed ID: 17401423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53: link to the past, bridge to the future.
    Mills AA
    Genes Dev; 2005 Sep; 19(18):2091-9. PubMed ID: 16166374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.